The Biobased and Renewable Products Advocacy Group (BRAG) helps members develop and bring to market their innovative biobased and renewable chemical products through insightful policy and regulatory advocacy. BRAG is managed by B&C® Consortia Management, L.L.C., an affiliate of Bergeson & Campbell, P.C.
Lauren M. Graham And Richard E. Engler Present At ABLC2018
  • Email This
  • Print
  • Share Link

On March 2, 2018, Lauren M. Graham, Ph.D., Manager of the Biobased and Renewable Products Advocacy Group (BRAG®), presented “Advocating for Commercialization of Biobased Products” at the 2018 Advanced Bioeconomy Leadership Conference (ABLC2018).  Dr. Graham presented as part of the “Federal Perspective & Programs Forum” alongside four other panelists.  Dr. Graham provided an overview of the Toxic Substances Control Act (TSCA) regulation impacting biobased chemicals and the regulatory barriers to the commercialization of such chemicals.  The presentation highlighted issues with the TSCA nomenclature system, as well as the work being done by BRAG to address the obstacles to commercialization and to engage in the implementation of new TSCA. If companies wish to ensure equitable regulations for biobased chemicals and products, they should consider joining BRAG to assist with future engagement with the U.S. Environmental Protection Agency (EPA).  For a copy of this presentation or for more information on BRAG, please contact Dr. Graham at .(JavaScript must be enabled to view this email address).
 
On March 1, 2018, Richard E. Engler, Ph.D., Senior Chemist for Bergeson & Campbell, P.C. (B&C®), presented “New TSCA and Biobased Innovation” at ABLC2018.  Dr. Engler presented as part of the Renewable Chemicals Summit and provided an overview of the impact new TSCA has had on EPA’s review of new chemicals under TSCA Section 5.  Pursuant to new TSCA Section 5, EPA must make an affirmative determination on every new chemical review, which has resulted in significant delays in the review process and increased regulation of new chemicals.  For a copy of this presentation, please contact Dr. Engler at .(JavaScript must be enabled to view this email address).

Tags: ABLC, TSCA